BridgeBio Pharma (BBIO) PT Raised to $89 at JPMorgan
Tweet
Share
E-mailGet Alerts BBIO Hot Sheet
Price: $72.44 -0.08%
Rating Summary:
25 Buy, 3 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 3 | Down: 5 | New: 34
Rating Summary:
25 Buy, 3 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 3 | Down: 5 | New: 34
Join SI Premium – FREE
JPMorgan analyst Anupam Rama raised the price target on BridgeBio Pharma (NASDAQ: BBIO) to $89.00 (from $77.00) while maintaining a Overweight rating.
You May Also Be Interested In
- BridgeBio Pharma (BBIO) PT Lowered to $23 at JPMorgan
- The Lovesac Co. (LOVE) PT Lowered to $18 at DA Davidson as Guidance Lowered
- H.C. Wainwright Reiterates Buy Rating on BridgeBio Pharma (BBIO)
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
